FDA Rejects Endo’s Deadline On Opana ER Petition; Impax Product May Become New RLD

Endo files suit against FDA seeking preliminary injunction to require FDA to say whether Endo’s withdrawal of non-crush resistant Opana ER was for safety reasons; FDA contends it has until May 10, 2013 to make this decision.